ClinConnect ClinConnect Logo
Search / Trial NCT04945174

Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions

Launched by HERLEV HOSPITAL · Jun 22, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Minor Stroke Stroke Prevention Physical Exercise Patient Education Cardiorespiratory Fitness Non Disabling Stroke

ClinConnect Summary

This clinical trial, called "Stroke School," is looking to see how a 12-week program that combines physical exercise, patient education, and individual follow-up sessions can help people who have experienced a minor stroke or a transient ischemic attack (TIA). The goal is to encourage physical activity to reduce the risk of heart problems and improve recovery after these types of strokes.

To join the study, participants need to be at least 18 years old and should have had a minor stroke or TIA recently. They should not require rehabilitation and must be able to speak and read Danish. The trial is especially for those who have not been very physically active lately, spending five hours or less on high-intensity activities per week. However, people with serious heart conditions or other health issues that make exercise difficult, as well as those with certain cognitive impairments, will not be eligible. Participants can expect to engage in guided exercises, learn about stroke prevention, and receive individual support throughout the trial. This could be a great opportunity for those looking to improve their health after a stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a minor stroke or TIA without the need of rehabilitation after hospital discharge, but need physical activity in order to prevent cardiovascular diseases
  • Patients spending ≤ 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months
  • Able to speak and read Danish and to provide informed consent
  • Individuals ≥ 18 years of age
  • Exclusion Criteria:
  • Previous large-artery stroke or hemorrhagic stroke
  • Unstable cardiac condition, e.g. pacemaker
  • Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines)
  • Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication)
  • Dyspnoea caused by heart or pulmonary disease (e.g. COPD)
  • Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations.
  • Patients diagnosed with dementia at hospital admission (a score ≤23/30 on the Mini-Mental State Examination are not invited into the study)

About Herlev Hospital

Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.

Locations

Herlev, , Denmark

Copenhagen, Herlev, Denmark

Patients applied

0 patients applied

Trial Officials

Christina Kruuse, Professor

Principal Investigator

Herlev Gentofte Hospital, Department of Neurology

Anders Hougaard, MD, Ph.d.

Study Director

Herlev Gentofte hospital, Department of Neurology,

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials